Global Implantable Cardioverter Defibrillator

Implantable Cardioverter Defibrillator Comprehensive Study by Type (Single Chambered, Dual Chambered, Biventricular Implantable Cardioverter Defibrillators), End user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), Procedure (Trans-Venous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators) Players and Region - Global Market Outlook to 2024

Implantable Cardioverter Defibrillator Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Scope of the Study
An implantable cardioverter defibrillator is used in treating sudden cardiac arrest caused due to and pulseless ventricular and ventricular fibrillation tachycardia. Implantable cardioverter defibrillator can save patients from arrhythmias by regulating the irregular heartbeats. It also helps to monitor the heart rate of the person with heart failure. Implantable cardioverter defibrillator market has high growth prospects owing to increasing number of patients with cardiovascular disorders. For instance, According to World Health Organization (WHO) in 2018, cardiovascular disease accounted for nearly 836,546 deaths in the United States in the United States and in 2017, 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). Further, technological advancement in the implantable cardioverter defibrillator expected to drive the demand for implantable cardioverter defibrillator market over the forecasted period.

The market study is being classified by Type (Single Chambered, Dual Chambered and Biventricular Implantable Cardioverter Defibrillators) and major geographies with country level break-up.

Microport Scientific Corporation (China), Imricor Medical Systems, Inc. (United States), LivaNova PLC Company (United Kingdom), Mayo Clinic US (United States), Medtronic plc (Ireland), St. Jude Medical Luxembourg Holding S.a. r.l (Luxembourg), MRI Interventions, Inc. (United States), Boston Scientific Corporation (United States), Mindray Medical International Limited (China) and Nihon Kohden (Japan) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Sorin Group (United States) and Boston Scientific Corporation (United States).

Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Implantable Cardioverter Defibrillator market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Implantable Cardioverter Defibrillator market by Type, Application and Region.

On the basis of geography, the market of Implantable Cardioverter Defibrillator has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End user , the sub-segment i.e. Hospitals will boost the Implantable Cardioverter Defibrillator market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Procedure, the sub-segment i.e. Trans-Venous Implantable Cardioverter Defibrillators will boost the Implantable Cardioverter Defibrillator market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Prevalence of Cardiovascular Disorders
  • Growing Government Initiatives for Training and Awareness Regarding Implantable Cardioverter Defibrillator

Market Trend
  • Emergence of Implantable Cardioverter Defibrillator
  • Technological Advancement in the Implantable Cardioverter Defibrillator

Restraints
  • Stringent Government Regulations Regarding Medical Devices
  • Lack of Trained Skilled Professionals

Opportunities
  • Rising Demand for Implantable Cardioverter Defibrillator from Developing Economies
  • Growing Healthcare Infrastructure Worldwide

Challenges
  • Lack of Awareness in the Emerging Economies





Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Type
  • Single Chambered
  • Dual Chambered
  • Biventricular Implantable Cardioverter Defibrillators
By End user
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Procedure
  • Trans-Venous Implantable Cardioverter Defibrillators
  • Subcutaneous Implantable Cardioverter Defibrillators

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Cardiovascular Disorders
      • 3.2.2. Growing Government Initiatives for Training and Awareness Regarding Implantable Cardioverter Defibrillator
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness in the Emerging Economies
    • 3.4. Market Trends
      • 3.4.1. Emergence of Implantable Cardioverter Defibrillator
      • 3.4.2. Technological Advancement in the Implantable Cardioverter Defibrillator
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Implantable Cardioverter Defibrillator, by Type, End user , Procedure and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Implantable Cardioverter Defibrillator (Value)
      • 5.2.1. Global Implantable Cardioverter Defibrillator by: Type (Value)
        • 5.2.1.1. Single Chambered
        • 5.2.1.2. Dual Chambered
        • 5.2.1.3. Biventricular Implantable Cardioverter Defibrillators
      • 5.2.2. Global Implantable Cardioverter Defibrillator by: Procedure (Value)
        • 5.2.2.1. Trans-Venous Implantable Cardioverter Defibrillators
        • 5.2.2.2. Subcutaneous Implantable Cardioverter Defibrillators
      • 5.2.3. Global Implantable Cardioverter Defibrillator Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Implantable Cardioverter Defibrillator (Volume)
      • 5.3.1. Global Implantable Cardioverter Defibrillator by: Type (Volume)
        • 5.3.1.1. Single Chambered
        • 5.3.1.2. Dual Chambered
        • 5.3.1.3. Biventricular Implantable Cardioverter Defibrillators
      • 5.3.2. Global Implantable Cardioverter Defibrillator by: Procedure (Volume)
        • 5.3.2.1. Trans-Venous Implantable Cardioverter Defibrillators
        • 5.3.2.2. Subcutaneous Implantable Cardioverter Defibrillators
      • 5.3.3. Global Implantable Cardioverter Defibrillator Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Implantable Cardioverter Defibrillator (Price)
      • 5.4.1. Global Implantable Cardioverter Defibrillator by: Type (Price)
  • 6. Implantable Cardioverter Defibrillator: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Microport Scientific Corporation (China)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Imricor Medical Systems, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. LivaNova PLC Company (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mayo Clinic US (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Medtronic plc (Ireland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. St. Jude Medical Luxembourg Holding S.a. r.l (Luxembourg)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. MRI Interventions, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Boston Scientific Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Mindray Medical International Limited (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Nihon Kohden (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Implantable Cardioverter Defibrillator Sale, by Type, End user , Procedure and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Implantable Cardioverter Defibrillator (Value)
      • 7.2.1. Global Implantable Cardioverter Defibrillator by: Type (Value)
        • 7.2.1.1. Single Chambered
        • 7.2.1.2. Dual Chambered
        • 7.2.1.3. Biventricular Implantable Cardioverter Defibrillators
      • 7.2.2. Global Implantable Cardioverter Defibrillator by: Procedure (Value)
        • 7.2.2.1. Trans-Venous Implantable Cardioverter Defibrillators
        • 7.2.2.2. Subcutaneous Implantable Cardioverter Defibrillators
      • 7.2.3. Global Implantable Cardioverter Defibrillator Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Implantable Cardioverter Defibrillator (Volume)
      • 7.3.1. Global Implantable Cardioverter Defibrillator by: Type (Volume)
        • 7.3.1.1. Single Chambered
        • 7.3.1.2. Dual Chambered
        • 7.3.1.3. Biventricular Implantable Cardioverter Defibrillators
      • 7.3.2. Global Implantable Cardioverter Defibrillator by: Procedure (Volume)
        • 7.3.2.1. Trans-Venous Implantable Cardioverter Defibrillators
        • 7.3.2.2. Subcutaneous Implantable Cardioverter Defibrillators
      • 7.3.3. Global Implantable Cardioverter Defibrillator Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Implantable Cardioverter Defibrillator (Price)
      • 7.4.1. Global Implantable Cardioverter Defibrillator by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Implantable Cardioverter Defibrillator: by Type(USD Million)
  • Table 2. Implantable Cardioverter Defibrillator Single Chambered , by Region USD Million (2013-2018)
  • Table 3. Implantable Cardioverter Defibrillator Dual Chambered , by Region USD Million (2013-2018)
  • Table 4. Implantable Cardioverter Defibrillator Biventricular Implantable Cardioverter Defibrillators , by Region USD Million (2013-2018)
  • Table 5. Implantable Cardioverter Defibrillator: by Procedure(USD Million)
  • Table 6. Implantable Cardioverter Defibrillator Trans-Venous Implantable Cardioverter Defibrillators , by Region USD Million (2013-2018)
  • Table 7. Implantable Cardioverter Defibrillator Subcutaneous Implantable Cardioverter Defibrillators , by Region USD Million (2013-2018)
  • Table 8. South America Implantable Cardioverter Defibrillator, by Country USD Million (2013-2018)
  • Table 9. South America Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 10. South America Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 11. South America Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 12. Brazil Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 13. Brazil Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 14. Brazil Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 15. Argentina Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 16. Argentina Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 17. Argentina Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 18. Rest of South America Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 19. Rest of South America Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 20. Rest of South America Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 21. Asia Pacific Implantable Cardioverter Defibrillator, by Country USD Million (2013-2018)
  • Table 22. Asia Pacific Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 23. Asia Pacific Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 24. Asia Pacific Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 25. China Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 26. China Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 27. China Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 28. Japan Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 29. Japan Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 30. Japan Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 31. India Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 32. India Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 33. India Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 34. South Korea Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 35. South Korea Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 36. South Korea Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 37. Taiwan Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 38. Taiwan Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 39. Taiwan Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 40. Australia Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 41. Australia Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 42. Australia Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 43. Rest of Asia-Pacific Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 44. Rest of Asia-Pacific Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 45. Rest of Asia-Pacific Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 46. Europe Implantable Cardioverter Defibrillator, by Country USD Million (2013-2018)
  • Table 47. Europe Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 48. Europe Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 49. Europe Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 50. Germany Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 51. Germany Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 52. Germany Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 53. France Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 54. France Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 55. France Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 56. Italy Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 57. Italy Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 58. Italy Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 59. United Kingdom Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 60. United Kingdom Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 61. United Kingdom Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 62. Netherlands Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 63. Netherlands Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 64. Netherlands Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 65. Rest of Europe Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 66. Rest of Europe Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 67. Rest of Europe Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 68. MEA Implantable Cardioverter Defibrillator, by Country USD Million (2013-2018)
  • Table 69. MEA Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 70. MEA Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 71. MEA Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 72. Middle East Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 73. Middle East Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 74. Middle East Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 75. Africa Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 76. Africa Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 77. Africa Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 78. North America Implantable Cardioverter Defibrillator, by Country USD Million (2013-2018)
  • Table 79. North America Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 80. North America Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 81. North America Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 82. United States Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 83. United States Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 84. United States Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 85. Canada Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 86. Canada Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 87. Canada Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 88. Mexico Implantable Cardioverter Defibrillator, by Type USD Million (2013-2018)
  • Table 89. Mexico Implantable Cardioverter Defibrillator, by End user USD Million (2013-2018)
  • Table 90. Mexico Implantable Cardioverter Defibrillator, by Procedure USD Million (2013-2018)
  • Table 91. Implantable Cardioverter Defibrillator Sales: by Type(Units)
  • Table 92. Implantable Cardioverter Defibrillator Sales Single Chambered , by Region Units (2013-2018)
  • Table 93. Implantable Cardioverter Defibrillator Sales Dual Chambered , by Region Units (2013-2018)
  • Table 94. Implantable Cardioverter Defibrillator Sales Biventricular Implantable Cardioverter Defibrillators , by Region Units (2013-2018)
  • Table 95. Implantable Cardioverter Defibrillator Sales: by Procedure(Units)
  • Table 96. Implantable Cardioverter Defibrillator Sales Trans-Venous Implantable Cardioverter Defibrillators , by Region Units (2013-2018)
  • Table 97. Implantable Cardioverter Defibrillator Sales Subcutaneous Implantable Cardioverter Defibrillators , by Region Units (2013-2018)
  • Table 98. South America Implantable Cardioverter Defibrillator Sales, by Country Units (2013-2018)
  • Table 99. South America Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 100. South America Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 101. South America Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 102. Brazil Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 103. Brazil Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 104. Brazil Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 105. Argentina Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 106. Argentina Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 107. Argentina Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 108. Rest of South America Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 109. Rest of South America Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 110. Rest of South America Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 111. Asia Pacific Implantable Cardioverter Defibrillator Sales, by Country Units (2013-2018)
  • Table 112. Asia Pacific Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 113. Asia Pacific Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 114. Asia Pacific Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 115. China Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 116. China Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 117. China Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 118. Japan Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 119. Japan Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 120. Japan Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 121. India Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 122. India Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 123. India Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 124. South Korea Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 125. South Korea Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 126. South Korea Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 127. Taiwan Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 128. Taiwan Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 129. Taiwan Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 130. Australia Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 131. Australia Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 132. Australia Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 133. Rest of Asia-Pacific Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 134. Rest of Asia-Pacific Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 135. Rest of Asia-Pacific Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 136. Europe Implantable Cardioverter Defibrillator Sales, by Country Units (2013-2018)
  • Table 137. Europe Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 138. Europe Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 139. Europe Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 140. Germany Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 141. Germany Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 142. Germany Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 143. France Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 144. France Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 145. France Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 146. Italy Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 147. Italy Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 148. Italy Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 149. United Kingdom Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 150. United Kingdom Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 151. United Kingdom Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 152. Netherlands Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 153. Netherlands Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 154. Netherlands Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 155. Rest of Europe Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 156. Rest of Europe Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 157. Rest of Europe Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 158. MEA Implantable Cardioverter Defibrillator Sales, by Country Units (2013-2018)
  • Table 159. MEA Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 160. MEA Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 161. MEA Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 162. Middle East Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 163. Middle East Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 164. Middle East Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 165. Africa Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 166. Africa Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 167. Africa Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 168. North America Implantable Cardioverter Defibrillator Sales, by Country Units (2013-2018)
  • Table 169. North America Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 170. North America Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 171. North America Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 172. United States Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 173. United States Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 174. United States Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 175. Canada Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 176. Canada Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 177. Canada Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 178. Mexico Implantable Cardioverter Defibrillator Sales, by Type Units (2013-2018)
  • Table 179. Mexico Implantable Cardioverter Defibrillator Sales, by End user Units (2013-2018)
  • Table 180. Mexico Implantable Cardioverter Defibrillator Sales, by Procedure Units (2013-2018)
  • Table 181. Implantable Cardioverter Defibrillator: by Type(USD/Units)
  • Table 182. Company Basic Information, Sales Area and Its Competitors
  • Table 183. Company Basic Information, Sales Area and Its Competitors
  • Table 184. Company Basic Information, Sales Area and Its Competitors
  • Table 185. Company Basic Information, Sales Area and Its Competitors
  • Table 186. Company Basic Information, Sales Area and Its Competitors
  • Table 187. Company Basic Information, Sales Area and Its Competitors
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Implantable Cardioverter Defibrillator: by Type(USD Million)
  • Table 193. Implantable Cardioverter Defibrillator Single Chambered , by Region USD Million (2019-2024)
  • Table 194. Implantable Cardioverter Defibrillator Dual Chambered , by Region USD Million (2019-2024)
  • Table 195. Implantable Cardioverter Defibrillator Biventricular Implantable Cardioverter Defibrillators , by Region USD Million (2019-2024)
  • Table 196. Implantable Cardioverter Defibrillator: by Procedure(USD Million)
  • Table 197. Implantable Cardioverter Defibrillator Trans-Venous Implantable Cardioverter Defibrillators , by Region USD Million (2019-2024)
  • Table 198. Implantable Cardioverter Defibrillator Subcutaneous Implantable Cardioverter Defibrillators , by Region USD Million (2019-2024)
  • Table 199. South America Implantable Cardioverter Defibrillator, by Country USD Million (2019-2024)
  • Table 200. South America Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 201. South America Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 202. South America Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 203. Brazil Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 204. Brazil Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 205. Brazil Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 206. Argentina Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 207. Argentina Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 208. Argentina Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 209. Rest of South America Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 210. Rest of South America Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 211. Rest of South America Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 212. Asia Pacific Implantable Cardioverter Defibrillator, by Country USD Million (2019-2024)
  • Table 213. Asia Pacific Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 214. Asia Pacific Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 215. Asia Pacific Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 216. China Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 217. China Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 218. China Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 219. Japan Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 220. Japan Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 221. Japan Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 222. India Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 223. India Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 224. India Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 225. South Korea Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 226. South Korea Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 227. South Korea Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 228. Taiwan Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 229. Taiwan Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 230. Taiwan Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 231. Australia Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 232. Australia Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 233. Australia Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 234. Rest of Asia-Pacific Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 235. Rest of Asia-Pacific Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 236. Rest of Asia-Pacific Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 237. Europe Implantable Cardioverter Defibrillator, by Country USD Million (2019-2024)
  • Table 238. Europe Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 239. Europe Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 240. Europe Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 241. Germany Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 242. Germany Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 243. Germany Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 244. France Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 245. France Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 246. France Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 247. Italy Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 248. Italy Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 249. Italy Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 250. United Kingdom Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 251. United Kingdom Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 252. United Kingdom Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 253. Netherlands Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 254. Netherlands Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 255. Netherlands Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 256. Rest of Europe Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 257. Rest of Europe Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 258. Rest of Europe Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 259. MEA Implantable Cardioverter Defibrillator, by Country USD Million (2019-2024)
  • Table 260. MEA Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 261. MEA Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 262. MEA Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 263. Middle East Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 264. Middle East Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 265. Middle East Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 266. Africa Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 267. Africa Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 268. Africa Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 269. North America Implantable Cardioverter Defibrillator, by Country USD Million (2019-2024)
  • Table 270. North America Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 271. North America Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 272. North America Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 273. United States Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 274. United States Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 275. United States Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 276. Canada Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 277. Canada Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 278. Canada Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 279. Mexico Implantable Cardioverter Defibrillator, by Type USD Million (2019-2024)
  • Table 280. Mexico Implantable Cardioverter Defibrillator, by End user USD Million (2019-2024)
  • Table 281. Mexico Implantable Cardioverter Defibrillator, by Procedure USD Million (2019-2024)
  • Table 282. Implantable Cardioverter Defibrillator Sales: by Type(Units)
  • Table 283. Implantable Cardioverter Defibrillator Sales Single Chambered , by Region Units (2019-2024)
  • Table 284. Implantable Cardioverter Defibrillator Sales Dual Chambered , by Region Units (2019-2024)
  • Table 285. Implantable Cardioverter Defibrillator Sales Biventricular Implantable Cardioverter Defibrillators , by Region Units (2019-2024)
  • Table 286. Implantable Cardioverter Defibrillator Sales: by Procedure(Units)
  • Table 287. Implantable Cardioverter Defibrillator Sales Trans-Venous Implantable Cardioverter Defibrillators , by Region Units (2019-2024)
  • Table 288. Implantable Cardioverter Defibrillator Sales Subcutaneous Implantable Cardioverter Defibrillators , by Region Units (2019-2024)
  • Table 289. South America Implantable Cardioverter Defibrillator Sales, by Country Units (2019-2024)
  • Table 290. South America Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 291. South America Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 292. South America Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 293. Brazil Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 294. Brazil Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 295. Brazil Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 296. Argentina Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 297. Argentina Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 298. Argentina Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 299. Rest of South America Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 300. Rest of South America Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 301. Rest of South America Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 302. Asia Pacific Implantable Cardioverter Defibrillator Sales, by Country Units (2019-2024)
  • Table 303. Asia Pacific Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 304. Asia Pacific Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 305. Asia Pacific Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 306. China Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 307. China Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 308. China Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 309. Japan Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 310. Japan Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 311. Japan Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 312. India Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 313. India Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 314. India Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 315. South Korea Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 316. South Korea Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 317. South Korea Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 318. Taiwan Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 319. Taiwan Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 320. Taiwan Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 321. Australia Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 322. Australia Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 323. Australia Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 324. Rest of Asia-Pacific Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 325. Rest of Asia-Pacific Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 326. Rest of Asia-Pacific Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 327. Europe Implantable Cardioverter Defibrillator Sales, by Country Units (2019-2024)
  • Table 328. Europe Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 329. Europe Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 330. Europe Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 331. Germany Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 332. Germany Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 333. Germany Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 334. France Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 335. France Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 336. France Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 337. Italy Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 338. Italy Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 339. Italy Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 340. United Kingdom Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 341. United Kingdom Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 342. United Kingdom Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 343. Netherlands Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 344. Netherlands Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 345. Netherlands Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 346. Rest of Europe Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 347. Rest of Europe Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 348. Rest of Europe Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 349. MEA Implantable Cardioverter Defibrillator Sales, by Country Units (2019-2024)
  • Table 350. MEA Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 351. MEA Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 352. MEA Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 353. Middle East Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 354. Middle East Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 355. Middle East Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 356. Africa Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 357. Africa Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 358. Africa Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 359. North America Implantable Cardioverter Defibrillator Sales, by Country Units (2019-2024)
  • Table 360. North America Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 361. North America Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 362. North America Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 363. United States Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 364. United States Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 365. United States Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 366. Canada Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 367. Canada Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 368. Canada Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 369. Mexico Implantable Cardioverter Defibrillator Sales, by Type Units (2019-2024)
  • Table 370. Mexico Implantable Cardioverter Defibrillator Sales, by End user Units (2019-2024)
  • Table 371. Mexico Implantable Cardioverter Defibrillator Sales, by Procedure Units (2019-2024)
  • Table 372. Implantable Cardioverter Defibrillator: by Type(USD/Units)
  • Table 373. Research Programs/Design for This Report
  • Table 374. Key Data Information from Secondary Sources
  • Table 375. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Implantable Cardioverter Defibrillator: by Type USD Million (2013-2018)
  • Figure 5. Global Implantable Cardioverter Defibrillator: by Procedure USD Million (2013-2018)
  • Figure 6. South America Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 7. Asia Pacific Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 8. Europe Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 9. MEA Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 10. North America Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 11. Global Implantable Cardioverter Defibrillator: by Type Units (2013-2018)
  • Figure 12. Global Implantable Cardioverter Defibrillator: by Procedure Units (2013-2018)
  • Figure 13. South America Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 14. Asia Pacific Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 15. Europe Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 16. MEA Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 17. North America Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 18. Global Implantable Cardioverter Defibrillator: by Type USD/Units (2013-2018)
  • Figure 19. Global Implantable Cardioverter Defibrillator share by Players 2018 (%)
  • Figure 20. Global Implantable Cardioverter Defibrillator share by Players (Top 3) 2018(%)
  • Figure 21. Global Implantable Cardioverter Defibrillator share by Players (Top 5) 2018(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Microport Scientific Corporation (China) Revenue, Net Income and Gross profit
  • Figure 24. Microport Scientific Corporation (China) Revenue: by Geography 2018
  • Figure 25. Imricor Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Imricor Medical Systems, Inc. (United States) Revenue: by Geography 2018
  • Figure 27. LivaNova PLC Company (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. LivaNova PLC Company (United Kingdom) Revenue: by Geography 2018
  • Figure 29. Mayo Clinic US (United States) Revenue, Net Income and Gross profit
  • Figure 30. Mayo Clinic US (United States) Revenue: by Geography 2018
  • Figure 31. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 32. Medtronic plc (Ireland) Revenue: by Geography 2018
  • Figure 33. St. Jude Medical Luxembourg Holding S.a. r.l (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 34. St. Jude Medical Luxembourg Holding S.a. r.l (Luxembourg) Revenue: by Geography 2018
  • Figure 35. MRI Interventions, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. MRI Interventions, Inc. (United States) Revenue: by Geography 2018
  • Figure 37. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 38. Boston Scientific Corporation (United States) Revenue: by Geography 2018
  • Figure 39. Mindray Medical International Limited (China) Revenue, Net Income and Gross profit
  • Figure 40. Mindray Medical International Limited (China) Revenue: by Geography 2018
  • Figure 41. Nihon Kohden (Japan) Revenue, Net Income and Gross profit
  • Figure 42. Nihon Kohden (Japan) Revenue: by Geography 2018
  • Figure 43. Global Implantable Cardioverter Defibrillator: by Type USD Million (2019-2024)
  • Figure 44. Global Implantable Cardioverter Defibrillator: by Procedure USD Million (2019-2024)
  • Figure 45. South America Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 46. Asia Pacific Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 47. Europe Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 48. MEA Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 49. North America Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 50. Global Implantable Cardioverter Defibrillator: by Type Units (2019-2024)
  • Figure 51. Global Implantable Cardioverter Defibrillator: by Procedure Units (2019-2024)
  • Figure 52. South America Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 53. Asia Pacific Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 54. Europe Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 55. MEA Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 56. North America Implantable Cardioverter Defibrillator Share (%), by Country
  • Figure 57. Global Implantable Cardioverter Defibrillator: by Type USD/Units (2019-2024)
List of companies from research coverage that are profiled in the study
  • Microport Scientific Corporation (China)
  • Imricor Medical Systems, Inc. (United States)
  • LivaNova PLC Company (United Kingdom)
  • Mayo Clinic US (United States)
  • Medtronic plc (Ireland)
  • St. Jude Medical Luxembourg Holding S.a. r.l (Luxembourg)
  • MRI Interventions, Inc. (United States)
  • Boston Scientific Corporation (United States)
  • Mindray Medical International Limited (China)
  • Nihon Kohden (Japan)
Additional players considered in the study are as follows:
Sorin Group (United States) , Boston Scientific Corporation (United States)
Select User Access Type

Key Highlights of Report


Jun 2019 235 Pages 53 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Implantable Cardioverter Defibrillator Quantitative research analysis
Global Implantable Cardioverter Defibrillator Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Implantable Cardioverter Defibrillator Report?

Have a Query? Click Here

Other Related Reports

Patient Warming Device Comprehensive Study by Type (Surface Warming Systems, Intravascular Warming Systems, Patient Warming Accessories), Application (Acute Care, Perioperative Care, New Born Care), ...
$ 3650
Slit Lamp Microscope Comprehensive Study by Type (Handheld Slit Lamp Microscope, Benchtop Slit Lamp Microscope, Others), Application (Cornea Examination, Iris Examination, Crystalline Lens Examinatio...
$ 3800
Bladeless Optical Trocars Comprehensive Study by Type (Disposable Trocars, Reusable Trocars), Application (General Surgery, Gynaecological Surgery, Urological Surgery, Pediatric Surgery, Other Surger...
$ 3650
Medical Perfusion System Comprehensive Study by Type (Bioreactor, Microfluidic, Gravity or Pressure-Driven, Small-Mammal Organ), Application (Cardiovascular Diseases, Respiratory Diseases), Component...
$ 3650
Electrosurgery Accessories Comprehensive Study by Type (Electrosurgery Generators, Electrosurgery Instruments, Electrosurgical Accessories), Application (General Surgery, Gynecology Surgery, Urologic...
$ 3750
Intrauterine Contraceptive Comprehensive Study by Type (Hormonal Intrauterine Device, Copper Intrauterine Device), Age Group (Age 15-24, Age 25-34, Age 35-44, Above 44), End User (Hospitals, Gynecolo...
$ 3450